- Home
- USCB vs GNFT Comparison
USCB vs GNFT Comparison
Compare USCB & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- GNFT
- Stock Information
- Founded
- USCB 2002
- GNFT 1999
- Country
- USCB United States
- GNFT France
- Employees
- USCB N/A
- GNFT N/A
- Industry
- USCB Major Banks
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- USCB Finance
- GNFT Health Care
- Exchange
- USCB Nasdaq
- GNFT Nasdaq
- Market Cap
- USCB 316.4M
- GNFT 214.5M
- IPO Year
- USCB 2021
- GNFT 2019
- Fundamental
- Price
- USCB $16.63
- GNFT $3.73
- Analyst Decision
- USCB Buy
- GNFT Strong Buy
- Analyst Count
- USCB 3
- GNFT 1
- Target Price
- USCB $20.50
- GNFT $13.00
- AVG Volume (30 Days)
- USCB 23.8K
- GNFT 3.9K
- Earning Date
- USCB 07-24-2025
- GNFT 04-24-2025
- Dividend Yield
- USCB 2.41%
- GNFT N/A
- EPS Growth
- USCB 78.48
- GNFT N/A
- EPS
- USCB 1.39
- GNFT 0.03
- Revenue
- USCB $84,457,000.00
- GNFT $73,187,701.00
- Revenue This Year
- USCB $23.28
- GNFT $15.98
- Revenue Next Year
- USCB $7.02
- GNFT N/A
- P/E Ratio
- USCB $11.93
- GNFT $123.55
- Revenue Growth
- USCB 34.16
- GNFT 105.01
- 52 Week Low
- USCB $11.88
- GNFT $2.55
- 52 Week High
- USCB $21.86
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- USCB 49.64
- GNFT 43.17
- Support Level
- USCB $16.08
- GNFT $3.55
- Resistance Level
- USCB $16.81
- GNFT $3.99
- Average True Range (ATR)
- USCB 0.35
- GNFT 0.16
- MACD
- USCB 0.03
- GNFT -0.06
- Stochastic Oscillator
- USCB 54.40
- GNFT 37.50
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.